|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02609 BAYZED HEALTH
Nominal 
4.340 -0.220 (-4.825%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,119,849 | -5.804% | 1,188,846 | 1,072,173 | 802,652 |
| Cost of Sales | (929,037) | -5.263% | (980,649) | (894,009) | (723,095) |
| Gross Profit | 190,812 | -8.350% | 208,197 | 178,164 | 79,557 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 9,292 | -30.198% | 13,312 | (4,610) | (62,524) | |
| Taxation | (17,970) | 6.527% | (16,869) | (19,796) | (12,991) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (4,279) | -56.778% | (9,900) | (1,983) | 17,497 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (12,957) | -3.716% | (13,457) | (26,389) | (58,018) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 17,553 | -6.816% | 18,837 | 25,851 | 23,120 |
| Depreciation & Amortisation | 90,916 | 4.028% | 87,396 | 86,271 | 74,544 |
| Directors' Emoluments | -- | -- | 6,570 | 5,994 | 5,109 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -1.000 | 0.000% | -1.000 | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.177 | -- | 0.142 | -- | -- |
| NBV per share ($) | 1.153 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -12,957 |
| %Change | -3.716% |
| EPS / (LPS) | RMB -0.010 |
| NBV Per Share (¥) | RMB 1.153 |